InvestorsHub Logo
Followers 37
Posts 2960
Boards Moderated 0
Alias Born 01/14/2003

Re: rosemountbomber post# 286642

Friday, 07/17/2020 8:38:00 AM

Friday, July 17, 2020 8:38:00 AM

Post# of 425892
Nahmias and tenOever spent the last three months studying what SARS-CoV-2 is doing to human lung cells. What they found is that the novel coronavirus prevents the routine burning of carbohydrates, which results in large amounts of fat accumulating inside lung cells – a condition the virus needs to reproduce.

Large amount of fat accumulation inside lung cells, is this referring to triglycerides?

“By understanding how the SARS-CoV-2 controls our metabolism, we can wrestle back control from the virus and deprive it from the very resources it needs to survive,” Nahmias said, noting that it also may help explain why patients with high blood sugar and cholesterol levels are often at a particularly high risk to develop COVID-19.

The team then reviewed a panel of eight already-approved drugs that could possibly interfere with the virus’s ability to reproduce. Tricor caused the cells to start burning fat, Nahmias said. The result was that the virus almost completely disappeared within only five days of treatment.

8 already approved drugs, approved where, in Israel?

I cannot tell, since Fenofibrate work well, does this mean Vascepa will also?


It's the ratio, baby ... the EPA/AA ratio!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News